BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 6396766)

  • 21. [Chemotherapy of breast cancers. Coordinated evolution of therapeutic schemes from 1975 to 1985].
    Chauvergne J; Durand M; Mauriac L; Hoerni B; David M
    Rev Fr Gynecol Obstet; 1986 Mar; 81(3):119-22. PubMed ID: 3085195
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Scandinavian trials with a short postoperative course versus a 12-cycle course.
    Nissen-Meyer R; Høst H; Kjellgren K; Månsson B; Norin T
    Recent Results Cancer Res; 1984; 96():48-54. PubMed ID: 6396779
    [No Abstract]   [Full Text] [Related]  

  • 23. Tamoxifen and combination chemotherapy as adjuvant treatment in postmenopausal women with breast cancer.
    Wallgren A; Baral E; Beling U; Carstensen J; Friberg S; Glas U; Kaigas M; Skoog L
    Recent Results Cancer Res; 1984; 96():197-203. PubMed ID: 6396775
    [No Abstract]   [Full Text] [Related]  

  • 24. Adjuvant systemic therapy for resectable breast cancer.
    Bonadonna G; Valagussa P
    J Clin Oncol; 1985 Feb; 3(2):259-75. PubMed ID: 3881562
    [No Abstract]   [Full Text] [Related]  

  • 25. Adjuvant therapy in primary breast cancer.
    Wolmark N; Fisher B
    Surg Clin North Am; 1985 Feb; 65(1):161-80. PubMed ID: 3887616
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The use of adjuvant chemotherapy for breast cancer in a community practice.
    Rosenberg A; Winer EP; Cadman E
    Conn Med; 1985 May; 49(5):281-5. PubMed ID: 3839177
    [No Abstract]   [Full Text] [Related]  

  • 27. Alternating versus sequential therapy in advanced breast cancer.
    Romero A; Rabinovich MG; Pérez JE; Macchiavelli M; Leone BA; Strauss E; Goldar D; Alvarez LA; Vallejo C
    Medicina (B Aires); 1987; 47(3):243-8. PubMed ID: 3326994
    [No Abstract]   [Full Text] [Related]  

  • 28. Short- or long-term chemotherapy for node-positive breast cancer: LMF 6 versus 18 cycles. SAKK study 27/76.
    Jungi WF; Alberto P; Brunner KW; Mermillod B; Barrelet L; Cavalli F
    Recent Results Cancer Res; 1984; 96():175-7. PubMed ID: 6396771
    [No Abstract]   [Full Text] [Related]  

  • 29. Role of adjuvant chemotherapy in male breast cancer.
    Patel HZ; Buzdar AU; Hortobagyi GN
    Cancer; 1989 Oct; 64(8):1583-5. PubMed ID: 2676137
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pattern of failure in patients with inflammatory breast cancer treated by alternating radiotherapy and chemotherapy.
    Thomas F; Arriagada R; Spielmann M; Mouriesse H; Le Chevalier T; Fontaine F; Tursz T
    Cancer; 1995 Dec; 76(11):2286-90. PubMed ID: 8635033
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Adriamycin/cyclophosphamide: current standard in adjuvant therapy for breast carcinoma?].
    Sauter C
    Schweiz Med Wochenschr; 1994 Oct; 124(43):1879-81. PubMed ID: 7973513
    [No Abstract]   [Full Text] [Related]  

  • 32. [First-line chemotherapy in operable breast neoplasms: results of 3 protocols].
    Cure H; Charrier S; Ferrière JP; Van Praagh I; Assier I; Feillel V; De Latour M; Bay JO; Achard JL; Dauplat J; Chollet P
    Bull Cancer; 1997 Jan; 84(1):31-4. PubMed ID: 9180856
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adjuvant chemotherapy for breast cancer. Implications of clinical trials.
    Carter SK
    Postgrad Med; 1985 Jan; 77(1):75-7, 80-3. PubMed ID: 3880891
    [No Abstract]   [Full Text] [Related]  

  • 34. [Treatment of metastatic breast cancer].
    Yahalom J; Biran S; Sulkes A
    Harefuah; 1986 Jul; 111(1-2):8-11. PubMed ID: 2430868
    [No Abstract]   [Full Text] [Related]  

  • 35. Combination chemotherapy of breast cancer.
    Cooper RG
    Mt Sinai J Med; 1985 Jun; 52(6):443-6. PubMed ID: 3875023
    [No Abstract]   [Full Text] [Related]  

  • 36. Postmenopausal node-positive comparison of observation with CMFP and CMPF + tamoxifen adjuvant therapy: an Eastern Cooperative Oncology Group trial.
    Tormey DC; Taylor SG; Gray R; Olson JE
    Recent Results Cancer Res; 1984; 96():110-6. PubMed ID: 6396764
    [No Abstract]   [Full Text] [Related]  

  • 37. Ludwig Breast Cancer trial LBCS III: chemo- and endocrine adjuvant treatment in postmenopausal patients.
    Gelber RD
    Recent Results Cancer Res; 1984; 96():102-9. PubMed ID: 6396763
    [No Abstract]   [Full Text] [Related]  

  • 38. [Randomized trial on the effect of radiotherapy in addition to 6 cycles CMF in node-positive breast cancer].
    Noël G; Mazeron JJ
    Cancer Radiother; 2001 Apr; 5(2):206-7. PubMed ID: 11355592
    [No Abstract]   [Full Text] [Related]  

  • 39. [Use of thymoptin and chemotherapy in the complex treatment of breast cancer].
    Skobel'tsyna ES; Gaĭseniuk LA; Kozyreva TV; Kalmykova IIa; Nikiforova NA
    Sov Med; 1991; (9):88. PubMed ID: 1798940
    [No Abstract]   [Full Text] [Related]  

  • 40. Doxorubicin and cyclophosphamide versus cyclophosphamide, methotrexate, and 5-fluorouracil as adjuvant chemotherapy in breast cancer.
    Livi L; Saieva C; Borghesi S; De Luca Cardillo C; Scotti V; Mangoni M; Greto D; Cataliotti L; Paiar F; Bianchi S; Biti GP
    J Chemother; 2009 Nov; 21(5):558-65. PubMed ID: 19933048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.